High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model

Gilpin, 2018 Blumberg, 2003, American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis, Am J Respir Crit Care Med, 167, 603, 10.1164/rccm.167.4.603 Gandhi, 2006, Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa, Lancet (London, England), 368, 1575, 10.1016/S0140-6736(06)69573-1 Haydel, 2010, Extensively drug-resistant tuberculosis: a sign of the times and an impetus for antimicrobial discovery, Pharmaceuticals, 3, 2268, 10.3390/ph3072268 Gomez, 2004, Tuberculosis persistence, latency, and drug tolerance, Tuberculosis, 84, 29, 10.1016/j.tube.2003.08.003 Boshoff, 2005, Tuberculosis - metabolism and respiration in the absence of growth, Nat Rev Microbiol, 3, 70, 10.1038/nrmicro1065 Chan, 2004, The immunological aspects of latency in tuberculosis, Clin Immunol, 110, 2, 10.1016/S1521-6616(03)00210-9 Rao, 2008, The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis, Proc Natl Acad Sci USA, 105, 11945, 10.1073/pnas.0711697105 Zhang, 2004, Persistent and dormant tubercle bacilli and latent tuberculosis, Front Biosci : J Virt Libr, 9, 1136, 10.2741/1291 Wayne, 1996, An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence, Infect Immun, 64, 2062, 10.1128/IAI.64.6.2062-2069.1996 Betts, 2002, Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling, Mol Microbiol, 43, 717, 10.1046/j.1365-2958.2002.02779.x Hussain, 2009, In vitro model of mycobacterial growth arrest using nitric oxide with limited air, Antimicrob Agents Chemother, 53, 157, 10.1128/AAC.00442-08 Fisher, 2002, Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes, J Bacteriol, 184, 4025, 10.1128/JB.184.14.4025-4032.2002 Deb, 2009, A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen, PloS One, 4, 10.1371/journal.pone.0006077 Wayne, 2001, Nonreplicating persistence of Mycobacterium tuberculosis, Annu Rev Microbiol, 55, 139, 10.1146/annurev.micro.55.1.139 Hashimoto, 1955, Kekkaku : Tuberculosis, 30, 4 Honore, 1995, Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 39, 769, 10.1128/AAC.39.3.769 Sala, 2010, Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis, Antimicrob Agents Chemother, 54, 4150, 10.1128/AAC.00821-10 Shandil, 2007, Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy, Antimicrob Agents Chemother, 51, 576, 10.1128/AAC.00414-06 Ackley, 2004, 151 Zhang, 2012, Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis, Antimicrob Agents Chemother, 56, 5782, 10.1128/AAC.01125-12 Gample, 2019, Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance, Sci Rep, 9, 9261, 10.1038/s41598-019-45652-8 Parveen, 2017, A short review on Sulphonamides with antimicrobial activity, Int J Pharmaceut Chem, 07, 70 Forgacs, 2009, Tuberculosis and trimethoprim-sulfamethoxazole, Antimicrob Agents Chemother, 53, 4789, 10.1128/AAC.01658-08 Brockmann, 1968, [The composition of resistomycin], Tetrahedron Lett, 3167, 10.1016/S0040-4039(00)89579-9 Haupt, 1972, [Effect of the antibiotics resistomycin and resistoflavin on growth, nucleic acid and protein synthesis in Bacillus subtilis], Z Allg Mikrobiol, 12, 575 Roggo, 1994, 3-Alkanoyl-5-hydroxymethyl tetronic acid homologues and resistomycin: new inhibitors of HIV-1 protease. I. Fermentation, isolation and biological activity, J Antibiot, 47, 136, 10.7164/antibiotics.47.136 Wong, 2012, Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics, Chem Biol, 19, 1483, 10.1016/j.chembiol.2012.09.014 Shiono, 2002, Effects of polyphenolic anthrone derivatives, resistomycin and hypercin, on apoptosis in human megakaryoblastic leukemia CMK-7 cell line, Z Naturforsch C J Biosci, 57, 923, 10.1515/znc-2002-9-1028 Zhang, 2013, Antifungal activities of metabolites produced by a termite-associated Streptomyces canus BYB02, J Agric Food Chem, 61, 1521, 10.1021/jf305210u Zhu, 2014, Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils, Microbiology (Read Engl), 160, 1714, 10.1099/mic.0.078295-0 Vijayabharathi, 2011, Assessment of resistomycin, as an anticancer compound isolated and characterized from Streptomyces aurantiacus AAA5, J Microbiol (Seoul, Korea), 49, 920 Gupta, 2013, In silico screening for identification of novel HIV-1 integrase inhibitors using QSAR and docking methodologies, Med Chem Res, 22, 5014, 10.1007/s00044-013-0490-y